From: Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis
Categories | Health Controls (n = 20) | Sepsis Patients (n = 79) | |
---|---|---|---|
Age, years | 61.8 ± 3.7 | 59.1 ± 2.0 | |
Male: Female ratio | 9:11 | 38:41 | |
Ethnicity | Caucasian, n(%) | 6 (30) | 50 (63.3) |
Hispanic, n(%) | 7 (35) | 14 (17.7) | |
Asian, n(%) | 0 (0) | 10 (12.7) | |
Black, n(%) | 7 (35) | 5 (6.3) | |
Comorbidities | |||
None, n(%) | 20 (100) | 18 (22.8) | |
Cardiovascular, n(%) | 0 (0) | 32 (40.5) | |
Respiratory, n(%) | 0 (0) | 23 (29.1) | |
Diabetes, n(%) | 0 (0) | 16 (20.3) | |
Chronic kidney disease, n(%) | 0 (0) | 6 (7.6) | |
Infection focus | |||
Respiratory tract infection, n(%) | N/A | 28 (35.4) | |
Urinary tract infection, n(%) | N/A | 26 (32.9) | |
Intra-abdominal infection, n(%) | N/A | 14 (17.7) | |
Others | N/A | 11 (13.9) | |
Acute Physiology and Chronic Health Evaluation II | N/A | 13.5 ± 3.7 | |
30-day mortality, n(%) | N/A | 9 (11.4) |